These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9794507)
1. Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations. Gaudreault J; Potvin D; Lavigne J; Lalonde RL Pharm Res; 1998 Oct; 15(10):1621-9. PubMed ID: 9794507 [TBL] [Abstract][Full Text] [Related]
2. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions. Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444 [TBL] [Abstract][Full Text] [Related]
3. Bioequivalence study of two different tablet formulations of donepezil using truncated areas under the curve. A single-center, single-dose, randomized, open-label, 2-way crossover study under fasting conditions. Almeida S; Filipe A; Neves R; Desjardins I; Shink E; Castillo A Arzneimittelforschung; 2010; 60(3):116-23. PubMed ID: 20422942 [TBL] [Abstract][Full Text] [Related]
4. The use of truncated area under the curves in the bioequivalence evaluation of long half-life drugs. Studies with donepezil and memantine. Erkent U; Koytchev R Arzneimittelforschung; 2008; 58(5):255-8. PubMed ID: 18589560 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of truncated areas in the assessment of bioequivalence of immediate release formulations of drugs with long half-lives and of Cmax with different dissolution rates. Sathe P; Venitz J; Lesko L Pharm Res; 1999 Jun; 16(6):939-43. PubMed ID: 10397617 [TBL] [Abstract][Full Text] [Related]
6. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives. Endrenyi L; Tothfalusi L Int J Clin Pharmacol Ther; 1997 Apr; 35(4):142-50. PubMed ID: 9112134 [TBL] [Abstract][Full Text] [Related]
7. Experimental, extrapolated and truncated areas under the concentration-time curve in bioequivalence trials. Marzo A; Monti NC; Vuksic D Eur J Clin Pharmacol; 1999 Nov; 55(9):627-31. PubMed ID: 10638390 [TBL] [Abstract][Full Text] [Related]
8. Effect of Different Sampling Schedules on Results of Bioavailability and Bioequivalence Studies: Evaluation by Means of Monte Carlo Simulations. Kano EK; Chiann C; Fukuda K; Porta V Drug Res (Stuttg); 2017 Aug; 67(8):451-457. PubMed ID: 28561232 [TBL] [Abstract][Full Text] [Related]
9. Use of truncated areas to measure extent of drug absorption in bioequivalence studies: effects of drug absorption rate and elimination rate variability on this metric. Kharidia J; Jackson AJ; Ouderkirk LA Pharm Res; 1999 Jan; 16(1):130-4. PubMed ID: 9950291 [TBL] [Abstract][Full Text] [Related]
10. Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model. Walker SE; Friesen MH J Pharm Pharm Sci; 1999; 2(1):15-22. PubMed ID: 10951658 [TBL] [Abstract][Full Text] [Related]
11. Truncated AUCs in the assessment of the bioequivalence of topiramate, a long half-life drug. Almeida S; Spínola AC; Filipe A; Trabelsi F; Farré A Arzneimittelforschung; 2007; 57(5):249-53. PubMed ID: 17598694 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax. el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554 [TBL] [Abstract][Full Text] [Related]
13. Bioequivalence of two rimantadine tablet formulations in healthy male volunteers after single dose administration. Chládek J; Sispera L; Martinková J; Zaludek B; Sova P; Mièuda S; Grim J; Cermanová J; Zaludek B; Sova P; Franc A Int J Clin Pharmacol Ther; 2001 Apr; 39(4):179-84. PubMed ID: 11332875 [TBL] [Abstract][Full Text] [Related]
14. Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations. Jackson AJ; Ouderkirk LA Pharm Res; 1999 Jul; 16(7):1144-6. PubMed ID: 10450946 [No Abstract] [Full Text] [Related]
15. Comparison of single and multiple dose pharmacokinetics using clinical bioequivalence data and Monte Carlo simulations. el-Tahtawy AA; Jackson AJ; Ludden TM Pharm Res; 1994 Sep; 11(9):1330-6. PubMed ID: 7816765 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence: performance of several measures of extent of absorption. Bois FY; Tozer TN; Hauck WW; Chen ML; Patnaik R; Williams RL Pharm Res; 1994 May; 11(5):715-22. PubMed ID: 8058642 [TBL] [Abstract][Full Text] [Related]
18. Impact of truncated area under the curve on failed bioequivalence studies: a computer simulation analysis. Mahmood I Drug Metabol Drug Interact; 2004; 20(1-2):77-83. PubMed ID: 15283304 [TBL] [Abstract][Full Text] [Related]
19. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults. Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174 [TBL] [Abstract][Full Text] [Related]
20. Comparative bioavailability study of doxycycline hyclate (equivalent to 100 mg doxycycline) capsules (doxycin vs vibramycin) for bioequivalence evaluation in healthy adult volunteers. Alsarra IA; Al-Said MS; Al-Khamis KI; Niazy EM; El-Sayed YM; Al-Rashood KA; Al-Yamani MJ; Al-Balla SA Int J Clin Pharmacol Ther; 2004 Jul; 42(7):373-7. PubMed ID: 15605689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]